US-based Kare ai Launches MedIntelGPT

US-based Kare ai launches MedIntelGPT- industry's first RAG-based conversational analytics Language Model tailored specifically for healthcare and life sciences.

MedIntelGPT combines the ability to generate custom insight in seconds from closed-sourced enterprise cloud in natural language and retrieve foundational insight from Kare’s core open-sourced LLM at the same time   – making it the most flexible and diverse conversational GPT for Medical Business Intelligence which is worth $12 billion today.

The beta version of MedIntelGPT is currently undergoing rigorous validation by a curated focus group that comprises leading business leaders, clinicians, medical researchers, PHDs, AI engineers, and data analysts.

The company claims to have a wait-list of 300+ focus-group members from 6 countries and several healthcare and pharmaceutical enterprises. MedIntelGPT which supports 94 global languages, is the first from a family of six AI-agents that Kare ai will launch over the next 12 months to pioneer conversational commerce across the entire medical value chain.

In India, MedIntelGPT will be launched with a select group of 9 enterprises and 3 academic institutions who are already in advanced talks with Kare ai.

Kare ai’s healthcare RAG LLM has believed to outperform major LLM models, especially when it comes to clinical intelligence, digital health analytics and conversational population health surveillance.